Owlstone, Thermo Fisher team up for early disease detection
If successful, Thermo’s mass analyser will become a standard part of Owlstone Medical’s biomarker discovery process.
Read More
Tag: markers
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
